1. AHRO : Austin Health Research Online

Louise M Burrell

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Louise M Burrell
Full Name
Burrell, Louise M
 
Title
Prof
 
Department
 
ORCID
Twitter
Loading... 3 0 20 0 false

Publications

Results 141-160 of 177 (Search time: 0.01 seconds).

Publication YearTitleAuthor(s)
1411-Jun-2000Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.Farina, N K; Johnston, Colin I; Burrell, Louise M 
1421-Mar-2000Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertension.Burrell, Louise M ; Risvanis, John; Johnston, Colin I; Naitoh, M; Balding, Leanne C
1431-Dec-1999Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy.Power, JM; Raman, Jai S ; Dornom, A; Farish, S J; Burrell, Louise M ; Tonkin, Andrew M; Buxton, Brian F ; Alferness, Clif A
14417-Sep-1999In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the rat.Risvanis, John; Naitoh, M; Johnston, Colin I; Burrell, Louise M 
1451-May-1999Localization of the insulin-like growth factor system in a rat model of heart failure induced by myocardial infarction.Dean, Rachael G; Edmondson, S R; Burrell, Louise M ; Bach, Leon A
1468-Dec-1998Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats.Yu, H C; Burrell, Louise M ; Black, M Jane; Wu, L L; Dilley, R J; Cooper, Mark E; Johnston, Colin I
1471-Oct-1998Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.Tikkanen, T; Tikkanen, Ilkka; Rockell, M D; Allen, Terri J; Johnston, Colin I; Cooper, Mark E; Burrell, Louise M 
1481-Jul-1998Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat.Burrell, Louise M ; Phillips, P A; Risvanis, John; Chan, Robert K ; Aldred, K L; Johnston, Colin I
14916-May-1998New hormonal blockade strategies in cardiovascular disease.Johnston, Colin I; Naitoh, M; Risvanis, John; Farina, N K; Burrell, Louise M 
15016-May-1998Thirst in elderly subjects.Naitoh, M; Burrell, Louise M 
15116-May-1998Effects of chronic AVP V2R blockade in congestive heart failure in sheep. Comparison with chronic ACE inhibition.Naitoh, M; Power, JM; Phillips, P A; Risvanis, John; Johnston, Colin I; Burrell, Louise M 
1521-May-1998Vasopressin V1a and V2 receptor mRNA in deoxycorticosterone acetate-salt hypertension in the rat.Risvanis, John; Johnston, Colin I; Phillips, P A; Burrell, Louise M 
1531-Apr-1998Susceptibility to atrial fibrillation: a study in an ovine model of pacing-induced early heart failure.Power, JM; Beacom, G A; Alferness, Clif A; Raman, Jai S ; Wijffels, M; Farish, S J; Burrell, Louise M ; Tonkin, Andrew M
1548-Jul-1997Chronic vasopressin antagonism in two-kidney, one-clip renovascular hypertension.Burrell, Louise M ; Risvanis, John; Phillips, P A; Naitoh, M; Johnston, Colin I
1551-Jul-1997Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495.Burrell, Louise M ; Farina, N K; Risvanis, John; Woollard, D; Casely, D; Johnston, Colin I
1561-Jun-1997Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease.Burrell, Louise M ; Johnston, Colin I
1571-Feb-1997Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR.Naitoh, M; Burrell, Louise M ; Risvanis, John; Aldred, K L; Rockell, M D; Johnston, Colin I; Phillips, P A
1581-Jan-1997A risk-benefit assessment of losartan potassium in the treatment of hypertension.Burrell, Louise M 
1597-Jun-1996Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in the rat.Burrell, Louise M ; Chan, R ; Phillips, P A; Calafiore, Paul ; Tonkin, Andrew M; Johnston, Colin I
1601-Dec-1995Differential effects of a novel non-peptide endothelin receptor antagonist (bosentan) in rat liver and vasculature.Phillips, P A; Risvanis, John; Aldred, K L; Burrell, Louise M ; Bartholomeusz, B